Article

jdsupra.comjdsupra.com on 2021-02-05 18:19

Biosimilars 2020 Year in Review

Introduction - The biosimilar pathway was designed to increase competition for biologics and reduce healthcare costs. Yet 2020 saw a slowdown in ...

Related news